Logo image of XCH

XCHG LTD (XCH) Stock Fundamental Analysis

NASDAQ:XCH - Nasdaq - US98370X1037 - ADR

1.18  -0.15 (-11.28%)

After market: 1.27 +0.09 (+7.63%)

Fundamental Rating

1

XCH gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 93 industry peers in the Electrical Equipment industry. Both the profitability and financial health of XCH have multiple concerns. XCH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

XCH had negative earnings in the past year.
XCH Yearly Net Income VS EBIT VS OCF VS FCFXCH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -2M -4M -6M -8M -10M

1.2 Ratios

XCH's Return On Assets of -25.04% is in line compared to the rest of the industry. XCH outperforms 40.66% of its industry peers.
The Return On Equity of XCH (-51.42%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -25.04%
ROE -51.42%
ROIC N/A
ROA(3y)-12.06%
ROA(5y)N/A
ROE(3y)-41.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XCH Yearly ROA, ROE, ROICXCH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -20 -40 -60 -80 -100

1.3 Margins

XCH has a better Gross Margin (46.05%) than 95.60% of its industry peers.
The Profit Margin and Operating Margin are not available for XCH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XCH Yearly Profit, Operating, Gross MarginsXCH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 20 -20 40

3

2. Health

2.1 Basic Checks

XCH does not have a ROIC to compare to the WACC, probably because it is not profitable.
XCH has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, XCH has a worse debt to assets ratio.
XCH Yearly Shares OutstandingXCH Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M 40M 50M
XCH Yearly Total Debt VS Total AssetsXCH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

XCH has an Altman-Z score of 1.86. This is not the best score and indicates that XCH is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.86, XCH is in line with its industry, outperforming 58.24% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that XCH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.45, XCH is in line with its industry, outperforming 45.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 1.86
ROIC/WACCN/A
WACC5.94%
XCH Yearly LT Debt VS Equity VS FCFXCH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

XCH has a Current Ratio of 1.92. This is a normal value and indicates that XCH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.92, XCH is in line with its industry, outperforming 50.55% of the companies in the same industry.
XCH has a Quick Ratio of 1.61. This is a normal value and indicates that XCH is financially healthy and should not expect problems in meeting its short term obligations.
XCH has a better Quick ratio (1.61) than 64.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.61
XCH Yearly Current Assets VS Current LiabilitesXCH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 10M 20M 30M

1

3. Growth

3.1 Past

The earnings per share for XCH have decreased strongly by -44200.00% in the last year.
Looking at the last year, XCH shows a very strong growth in Revenue. The Revenue has grown by 30.89%.
EPS 1Y (TTM)-44200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)30.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XCH Yearly Revenue VS EstimatesXCH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 10M 20M 30M
XCH Yearly EPS VS EstimatesXCH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XCH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XCH Price Earnings VS Forward Price EarningsXCH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XCH Per share dataXCH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for XCH!.
Industry RankSector Rank
Dividend Yield N/A

XCHG LTD

NASDAQ:XCH (1/21/2025, 8:00:02 PM)

After market: 1.27 +0.09 (+7.63%)

1.18

-0.15 (-11.28%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap70.15M
AnalystsN/A
Price TargetN/A
Short Float %0.68%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.82
P/FCF N/A
P/OCF N/A
P/B 3.45
P/tB 3.45
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.65
BVpS0.34
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.04%
ROE -51.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.05%
FCFM N/A
ROA(3y)-12.06%
ROA(5y)N/A
ROE(3y)-41.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.61
Altman-Z 1.86
F-ScoreN/A
WACC5.94%
ROIC/WACCN/A
Cap/Depr(3y)152.26%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.93%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-484.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1060.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-756.95%
OCF growth 3YN/A
OCF growth 5YN/A